2022 SPEAKERS & COMPANIES

Key Scientists & Experts

Sandra Kaufmann, MD

Author and Creator of the Kaufmann Protocol

Timothy Nelson, MD, PhD

Founder & CEO, Heartworks

Alessandra Zonari, PhD

Co-Founder and Chief Scientific Officer, OneSkin

Robin Mansukhani

CEO and Co-Founder, Deciduous Therapeutics

Kyle Zagrodsky

Founder & CEO, OsteoStrong Franchising

Joshua Ofman, MD, MSHS

President and Chief Medical Officer

Daniel Kraft, MD

Founder & Chair, Exponential Medicine

Josh Clemente

Founder, Levels

Jon Carder

Co-Founder & CEO, Vessel Health

Dr. Trevor Martin

Co Founder, Mammoth Biosciences

Kristen Fortney, PhD

Co Founder and CEO, BioAge

Naveen Jain

Author, Moonshots: Creating a World of Abundance

Morgan Levine, PhD

Founding Principal Investigator, Altos Labs

Daniel Oliver

Co Founder and CEO, Rejuvenate Bio

Dean Ornish, MD

Founder and President, Preventive Medicine Research Institute

Priya Abani

CEO, President, and Board Member, AliveCor

James Min, MD

Founder and CEO, Cleerly

Katerina Akassoglou, PhD

Professor of Neurology, UC San Francisco (UCSF)

Yadong Huang, MD, PhD

Scientific Co-Founder, GABAeron

Mary Lou Jepsen, PhD

CEO and Founder, OpenWater

James Nestor

Science Journalist and Author, Breath

Tara Tracy, PhD

Assistant Professor, Buck Institute for Research on Aging

Seth Shipman, PHD

Assistant Professor, Gladstone Institutes at UCSF

Eric Verdin, MD

President and CEO, Buck Institute for Research on Aging

Melanie Ott, MD, PhD

Director, Gladstone Institute of Virology

George Shapiro, MD

Chief Medical Innovation Officer, Fountain Life

Matt Walker, PhD

Professor, UC Berkeley

Bjoern Woltermann

Founder & CEO, Katalyst

Denitsa Milanova, PhD

Fellow & PI, Marble Therapeutics

Sandeep Akkaraju

CEO & President, Exo Imaging

Shinya Yamanaka, MD, PhD

Nobel Prize laureate & L.K. Whittier Foundation Investigator in Stem Cell Biology, Gladstone Institutes

Greg Bailey, MD

CEO, Juvenescence

Hector L. LopezMD, CSCS, FAAPMR

Chief Research and Innovation Advisor, LIFEFORCE

Carolina Reis

CEO, OneSkin

Leor Weinberger, PhD

Co-Founder, VxBiosciences

John Jaquish, PhD

Inventor, OsteoStrong Devices

Kenneth R. Brown, DDS

Co-Founder & CEO, Feno

Jennifer Garrison, PhD

Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality

David Furman, PhD

Associate Professor, Buck Institute for Research on Aging

Isha Jain, PhD

Assistant Professor, Gladstone Institutes and UCSF

Kyle Zagrodzky

Founder & CEO, OsteoStrong Franchising

Deepak Srivastava, MD

President, Gladstone Institutes

David Fagjenbaum, MD

Physician-Scientist, University of Pennsylvania

Brianna Stubbs, PhD

Lead Translational Scientist, Buck Institute for Research on Aging

Noah Davidsohn, PhD

CSO, Co-Founder, Rejuvenate Bio

Kent Wakeford

Co Founder, Chief Operating Officer, Colossal

Alex Aravanis MD PhD

Chief Technology Officer, Illumina

Remy Gross III

Vice President, Business Development and Technology Advancement, Buck Institute for Research on Aging

Program Agenda

  • cancer cancer-black
    Cancer
    Joshua Ofman, MD, MSHS
    Chief Medical Officer
    GRAIL

    Read Bio
    Naveen Jain
    Founder & CEO
    Viome Life Sciences

    Read Bio
    Mary Lou Jepsen, PhD
    CEO and Founder
    OpenWater

    Read Bio
  • heart-black heart-white
    Heart / Cardiovascular
    Priya Abani
    Chief Executive Officer
    AliveCor

    Read Bio
    James Min, MD
    Founder and CEO
    Cleerly

    Read Bio
    Katerina Akassoglou, PhD
    Professor of Neurology
    UC San Francisco (UCSF)

    Read Bio
    Deepak Srivastava, MD
    President
    Gladstone Institutes

    Read Bio
    Dr. Brianna Stubbs
    Lead Translational Scientist
    Buck Institute for Research on Aging

    Read Bio
    Timothy Nelson, MD, PhD
    Founder & CEO
    Heartworks

    Read Bio
  • alzheimer-black alzheimer-white
    Alzheimers & Brain
    Yadong Huang, MD, PhD
    Scientific Co-Founder
    GABAeron

    Read Bio
    Mary Lou Jepsen, PhD
    CEO and Founder
    OpenWater

    Read Bio
    Tara Tracy, PhD
    Assistant Professor
    Buck Institute for Research on Aging

    Read Bio
    Eric Verdin, MD
    President and CEO
    Buck Institute for Research on Aging

    Read Bio
    Melanie Ott, MD, PhD
    Director
    Gladstone Institute of Virology

    Read Bio
  • biology-black biology-white
    Biology & Aging
    Sandra Kaufmann, MD
    Author & Creator
    The Kaufmann Anti-Aging Institute

    Read Bio
    Kristen Fortney, PhD
    Co Founder and CEO
    BioAge

    Read Bio
    George Shapiro, MD
    Chief Medical Innovation Officer
    Fountain Life

    Read Bio
    David Furman, PhD
    Associate Professor
    Buck Institute for Research on Aging

    Read Bio
  • crispr-1 crispr-white
    CRISPR
    Dr. Trevor Martin
    Co-Founder
    Mammoth BioSciences

    Read Bio
    Seth Shipman, PHD
    Assistant Professor
    Gladstone Institutes at UCSF

    Read Bio
    Kent Wakeford
    Co Founder, Chief Operating Officer
    Colossal Biosciences

    Read Bio
  • self-care self-care-white
    Self Care
    Josh Clemente
    Founder
    Levels

    Read Bio
    Naveen Jain
    Founder & CEO
    Viome Life Sciences

    Read Bio
    Matt Walker, PhD
    Professor
    UC Berkeley

    Read Bio
    James Nestor
    Science Journalist and Author
    Breath

    Read Bio
  • imaging imaging-white
    Imaging
    Sandeep Akkaraju
    Co-Founder and Chief Executive Officer
    Exo Imaging

    Read Bio
    James Min, MD
    Founder and CEO
    Cleerly

    Read Bio
    Dr. Mary Lou Jepsen
    CEO and Founder
    OpenWater

    Read Bio
  • gene-therapy gene-therapy-white
    Gene Therapy & Epigenetics
    Morgan Levine, PhD
    Founding Principal Investigator
    Altos Labs

    Read Bio
    Daniel Oliver
    CEO and Founder
    Rejuvenate Bio

    Read Bio
    Shinya Yamanaka, MD, PhD
    Nobel Prize laureate & L.K. Whittier Foundation Investigator in Stem Cell Biology
    Gladstone Institutes

    Read Bio
    Denitsa Milanova, PhD
    Fellow & PI
    Marble Therapeutics

    Read Bio
    Noah Davidsohn, PhD
    CSO, Co-Founder
    Rejuvenate Bio

    Alex Aravanis, MD PhD
    Chief Technology Officer
    Illumina

    Read Bio
  • reproductive-health reproductive-health-white
    Reproductive Health
    Jennifer Garrison, PhD
    Co-Founder & Director
    Global Consortium for Reproductive Longevity & Equality

    Read Bio
  • auto-immunity auto-immunity-white
    Inflammation and the Immune System
    Robin Mansukhani
    CEO
    Deciduous Therapeutics

    Read Bio
    Greg Bailey, MD
    CEO
    Juvenescence

    Read Bio
    David Fagjenbaum, MD
    Physician-Scientist
    University of Pennsylvania

    Read Bio
    Leor Weinberger, PhD
    Co-Founder
    VxBiosciences

    Read Bio
  • hormone-optimisation hormone-optimisation-white
    Nutraceuticals, Hormone Optimization & Diet
    Hector L. LopezMD, CSCS, FAAPMR
    Chief Research and Innovation Advisor
    LIFEFORCE

    Read Bio
    Dean Ornish, MD
    Founder and President
    Preventive Medicine Research Institute

    Read Bio
    Dr. Brianna Stubbs
    Lead Translational Scientist
    Buck Institute for Research on Aging

    Read Bio
  • exponential-medicine exponential-medicine-white
    Exponential Tech & Medicine
    Daniel Kraft, MD
    Founder & Chair
    Exponential Medicine

    Read Bio
    Peter Diamandis, MD
    Founder & Executive Chairman
    XPRIZE Foundation

  • exercise-black exercise-white
    Exercise
    Bjoern Woltermann
    Founder & CEO
    Katalyst

    Read Bio
    Kyle Zagrodzky
    Founder & CEO
    OsteoStrong Franchising

    Read Bio
    John Jaquish, PhD
    Inventor
    OsteoStrong Devices

    Read Bio
  • At-Home Diagnostics Black At-Home Diagnostics White
    At-Home Diagnostics
    Kenneth R. Brown, DDS
    Co-Founder & CEO
    Feno

    Read Bio
    Jon Carder
    Co-Founder & CEO
    Vessel Health

    Read Bio
    Priya Abani
    Chief Executive Officer
    AliveCor

    Read Bio
  • Aesthetics-black Aesthetics-white
    Aesthetics
    Carolina Reis
    CEO
    OneSkin

    Alessandra Zonari, PhD
    Co-Founder and Chief Scientific Officer
    OneSkin

    Read Bio
    Denitsa Milanova, PhD
    Fellow & PI
    Marble Therapeutics

    Read Bio
  • investing-black investing-white
    Investing
    Neal Bhadkamkar
    General Partner
    Bold Capital Partners

    Read Bio
    Maxx Bricklin
    General Partner
    Bold Capital Partners

    Read Bio
    Sergey Young
    General Partner
    Bold Capital Partners

    Read Bio
    Remy Gross III
    Vice President, Business Development and Technology Advancement
    Buck Institute for Research on Aging

    Read Bio
  • lungs-black lungs-white
    Lungs
    Isha Jain, PhD
    Assistant Professor
    Gladstone Institutes and UCSF

    Read Bio

Longevity & Biotech Topics

Delve into the next decade of longevity and biotechnology innovations across:

Regenerative Medicine
Cancer Detection, Prevention & Therapies
Sirtuin Activators
Gene Therapy & CRISPR
Brain Health & Neurodegenerative Diseases
Tissue & Organ Engineering
Brain-Immune-Gut Axis
Senolytic Medicines
Increasing Vitality

A 5-day Longevity Deep-Dive with Peter Diamandis, MD

The 2022 Platinum Longevity Trip is a luxury 5-day deep dive into the future of your health, spanning key therapies, research, and novel breakthroughs that will define the next decade of longevity: regenerative medicine and stem cell therapies, advancements in brain health and prevention of neurodegenerative diseases, CRISPR and gene therapies, senolytic medicines, advanced diagnostics, and others.

The trip offers first-hand exposure to the pioneering founders, scientists, startups, public biotech companies and treatments in longevity and vitality. Gain an exclusive view of what is coming our way this next decade in personalized, preventive medicine, and rejuvenation treatments.

Untitled-2

High-Level details

What's Included

  • 5-star accommodation
  • Private charter service & all internal transit
  • Haute cuisine menus
  • Wellness treatments
  • Advanced diagnostics

Cost

Individual Rate: $70,000

Couple's Rate: $65,000 / person

Day 1-3: San Francisco
Mask Group 38
Trip 1: Aug 10-12
Trip 2: Sep 14-16
Day 4: Verijet Private Flight to San Diego
Mask Group 39
Trip 1: Aug 13
Trip 2: Sept 17
Day 4-5: San Diego
Mask Group 40
Trip 1: Aug 13-14
Trip 2: Sept 17-18

Personalized for 35 extraordinary people

 

Limited to an exclusive group of serious players (C-suite executives, investors, industry leaders) worldwide, Abundance Platinum is about fostering lifelong friendships.

Our group will additionally be joined by resident longevity experts that will accompany and advise members throughout the trip.

Through a personalization process, Peter and his team work to determine what therapies, health concerns (involving family medical history), investment interests, and conditions are most important to you. The experience is then curated through our various symposiums, featured treatments, and hosted experts to emphasize your most pressing interests.

Trip overview by topic

Day 0


Itinerary

  • Arrive in San Francisco
  • Check in: St. Regis San Francisco

Day 1


Topics

  • Gene Therapy
  • Young Blood & GDF11
  • Brain-Immune-Gut Axis
  • CRISPR & Genetic Engineering

Day 2


Topics

  • Tissue Engineering
  • Sensors & Wearables
  • COVID-19 & Future of Pandemics
  • Regenerative Medicine
  • Brain Health

Day 3


Topics

  • Neurodegenerative Diseases
  • Cardiovascular Health
  • Oncology & Cancer Therapies
  • NAD+ / Sirtuins Diagnostics Biofabrication

Day 4


Itinerary

  • Flight to San Diego
  • Check in: Park Hyatt Aviara

Topics

  • Biological Mechanics of Aging
  • Cellular Therapies

Day 5


Topics

  • Stem Cells
  • Drug Discovery: Age-Related Diseases
  • Organ Procurement
  • The Future of Aging
  • Closing Reception

Message from Peter H. Diamandis, MD

My mission is to transform your mindset around longevity. To give you overwhelming evidence of the massive medical advancements that are already beginning to extend the human healthspan.

Now more than ever, during a period of exponential medicine, you don’t have to accept the cards you’re dealt. Technologies like genome sequencing, RNA transcriptomics, Wnt pathway modifiers, vaccines, CRISPR, liquid biopsies, CAR-T cells, Gene Therapy, exosomes, and stem cells are just a few of the technologies under development. My goal through these 5 days is to fundamentally reframe your concept of aging as a disease -- a disease that many are beginning to believe can be slowed, stopped and perhaps even reversed.

Join me on the journey of a lifetime, get a behind-the-scenes look at the decade ahead in longevity-extending technologies, and begin adding healthy decades onto your life.

About Peter

Fortune Magazine named Diamandis as one of the World’s 50 Greatest Leaders. He is the Founder & Executive Chairman of the XPRIZE Foundation and Executive Founder of Singularity University and has co-Founded 20 companies including Celularity, Human Longevity Inc., and BOLD Capital Partners. Diamandis is the NY Times Bestselling author of Abundance and BOLD. He earned degrees in Molecular Genetics and Aerospace Engineering from MIT, and an MD from Harvard Medical School.